Calcium in PDB 2ary: Catalytic Domain of Human Calpain-1
Enzymatic activity of Catalytic Domain of Human Calpain-1
All present enzymatic activity of Catalytic Domain of Human Calpain-1:
3.4.22.52;
Protein crystallography data
The structure of Catalytic Domain of Human Calpain-1, PDB code: 2ary
was solved by
J.R.Walker,
T.Davis,
V.Lunin,
E.M.Newman,
F.Mackenzie,
J.Weigelt,
M.Sundstrom,
C.Arrowsmith,
A.Edwards,
A.Bochkarev,
S.Dhe-Paganon,
Structural Genomics Consortium (Sgc),
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
44.32 /
2.40
|
Space group
|
P 61 2 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
90.534,
90.534,
433.102,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
22 /
26.4
|
Calcium Binding Sites:
The binding sites of Calcium atom in the Catalytic Domain of Human Calpain-1
(pdb code 2ary). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 4 binding sites of Calcium where determined in the
Catalytic Domain of Human Calpain-1, PDB code: 2ary:
Jump to Calcium binding site number:
1;
2;
3;
4;
Calcium binding site 1 out
of 4 in 2ary
Go back to
Calcium Binding Sites List in 2ary
Calcium binding site 1 out
of 4 in the Catalytic Domain of Human Calpain-1
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Catalytic Domain of Human Calpain-1 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca401
b:32.4
occ:1.00
|
O
|
A:VAL99
|
2.3
|
36.9
|
1.0
|
O
|
A:GLY101
|
2.3
|
27.7
|
1.0
|
O
|
A:HOH403
|
2.4
|
31.1
|
1.0
|
OD2
|
A:ASP106
|
2.4
|
32.3
|
1.0
|
O
|
A:HOH406
|
2.4
|
36.2
|
1.0
|
OD1
|
A:ASP106
|
2.6
|
30.6
|
1.0
|
OE2
|
A:GLU185
|
2.6
|
32.8
|
1.0
|
OE1
|
A:GLU185
|
2.7
|
30.8
|
1.0
|
CG
|
A:ASP106
|
2.8
|
32.5
|
1.0
|
CD
|
A:GLU185
|
3.0
|
31.5
|
1.0
|
C
|
A:VAL99
|
3.5
|
36.5
|
1.0
|
C
|
A:GLY101
|
3.6
|
31.6
|
1.0
|
O
|
A:ASP100
|
3.9
|
35.3
|
1.0
|
C
|
A:ASP100
|
4.1
|
35.8
|
1.0
|
N
|
A:VAL99
|
4.1
|
36.1
|
1.0
|
O
|
A:HOH425
|
4.2
|
41.2
|
1.0
|
CB
|
A:ASP106
|
4.2
|
32.4
|
1.0
|
CA
|
A:VAL99
|
4.3
|
36.6
|
1.0
|
N
|
A:GLY101
|
4.3
|
34.2
|
1.0
|
OG1
|
A:THR103
|
4.3
|
25.9
|
1.0
|
N
|
A:THR103
|
4.4
|
26.9
|
1.0
|
N
|
A:ASP100
|
4.5
|
36.7
|
1.0
|
CG
|
A:GLU185
|
4.5
|
28.5
|
1.0
|
NE1
|
A:TRP187
|
4.5
|
32.3
|
1.0
|
N
|
A:ALA102
|
4.5
|
31.0
|
1.0
|
CB
|
A:VAL99
|
4.5
|
36.3
|
1.0
|
CA
|
A:GLY101
|
4.5
|
32.5
|
1.0
|
CA
|
A:ALA102
|
4.6
|
29.3
|
1.0
|
CA
|
A:ASP100
|
4.7
|
36.3
|
1.0
|
OG
|
A:SER180
|
4.7
|
30.6
|
1.0
|
CB
|
A:ASP100
|
4.9
|
37.6
|
1.0
|
O
|
A:HOH502
|
4.9
|
38.5
|
1.0
|
OG1
|
A:THR105
|
4.9
|
35.0
|
1.0
|
C
|
A:ALA102
|
5.0
|
27.6
|
1.0
|
|
Calcium binding site 2 out
of 4 in 2ary
Go back to
Calcium Binding Sites List in 2ary
Calcium binding site 2 out
of 4 in the Catalytic Domain of Human Calpain-1
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Catalytic Domain of Human Calpain-1 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca402
b:31.6
occ:1.00
|
O
|
A:GLU333
|
2.3
|
32.2
|
1.0
|
O
|
A:HOH414
|
2.3
|
30.5
|
1.0
|
O
|
A:MET329
|
2.3
|
46.4
|
1.0
|
OE1
|
A:GLU302
|
2.5
|
32.0
|
1.0
|
OD1
|
A:ASP331
|
2.5
|
42.4
|
1.0
|
OD2
|
A:ASP309
|
2.6
|
40.6
|
1.0
|
OE2
|
A:GLU302
|
2.8
|
39.0
|
1.0
|
CD
|
A:GLU302
|
2.9
|
35.8
|
1.0
|
OD1
|
A:ASP309
|
3.1
|
36.1
|
1.0
|
CG
|
A:ASP309
|
3.2
|
38.0
|
1.0
|
C
|
A:GLU333
|
3.5
|
31.0
|
1.0
|
CG
|
A:ASP331
|
3.5
|
37.6
|
1.0
|
C
|
A:MET329
|
3.6
|
47.6
|
1.0
|
OD2
|
A:ASP331
|
3.9
|
36.5
|
1.0
|
O
|
A:VAL327
|
4.0
|
42.8
|
1.0
|
N
|
A:ASP331
|
4.0
|
40.5
|
1.0
|
N
|
A:GLU333
|
4.1
|
31.3
|
1.0
|
N
|
A:MET329
|
4.2
|
48.6
|
1.0
|
CA
|
A:GLU333
|
4.3
|
31.1
|
1.0
|
CG
|
A:GLU302
|
4.4
|
33.0
|
1.0
|
CA
|
A:MET329
|
4.4
|
50.3
|
1.0
|
N
|
A:PHE334
|
4.5
|
30.5
|
1.0
|
N
|
A:GLU330
|
4.5
|
47.1
|
1.0
|
O
|
A:HOH441
|
4.6
|
33.7
|
1.0
|
CA
|
A:GLU330
|
4.6
|
46.1
|
1.0
|
CB
|
A:ASP331
|
4.7
|
36.8
|
1.0
|
CB
|
A:ASP309
|
4.7
|
37.9
|
1.0
|
CA
|
A:PHE334
|
4.7
|
30.0
|
1.0
|
CB
|
A:GLU333
|
4.7
|
30.4
|
1.0
|
O
|
A:HOH407
|
4.7
|
28.7
|
1.0
|
N
|
A:GLY332
|
4.7
|
34.7
|
1.0
|
CA
|
A:ASP331
|
4.7
|
37.7
|
1.0
|
CB
|
A:PHE334
|
4.9
|
28.7
|
1.0
|
C
|
A:GLU330
|
4.9
|
43.9
|
1.0
|
CB
|
A:MET329
|
4.9
|
50.3
|
1.0
|
O
|
A:HOH415
|
4.9
|
33.0
|
1.0
|
C
|
A:ASP331
|
5.0
|
35.3
|
1.0
|
|
Calcium binding site 3 out
of 4 in 2ary
Go back to
Calcium Binding Sites List in 2ary
Calcium binding site 3 out
of 4 in the Catalytic Domain of Human Calpain-1
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Catalytic Domain of Human Calpain-1 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca404
b:40.4
occ:1.00
|
O
|
B:GLY101
|
2.3
|
40.1
|
1.0
|
O
|
B:VAL99
|
2.4
|
48.5
|
1.0
|
O
|
B:HOH442
|
2.4
|
47.3
|
1.0
|
OD2
|
B:ASP106
|
2.6
|
40.3
|
1.0
|
OD1
|
B:ASP106
|
2.6
|
41.5
|
1.0
|
OE2
|
B:GLU185
|
2.6
|
47.6
|
1.0
|
OE1
|
B:GLU185
|
2.7
|
48.2
|
1.0
|
CG
|
B:ASP106
|
2.9
|
39.4
|
1.0
|
CD
|
B:GLU185
|
3.0
|
47.1
|
1.0
|
C
|
B:VAL99
|
3.6
|
49.0
|
1.0
|
C
|
B:GLY101
|
3.6
|
41.6
|
1.0
|
O
|
B:ASP100
|
3.8
|
48.2
|
1.0
|
C
|
B:ASP100
|
4.0
|
47.3
|
1.0
|
OG1
|
B:THR103
|
4.1
|
44.7
|
1.0
|
N
|
B:VAL99
|
4.2
|
49.2
|
1.0
|
N
|
B:THR103
|
4.3
|
42.0
|
1.0
|
CB
|
B:ASP106
|
4.3
|
40.1
|
1.0
|
N
|
B:GLY101
|
4.4
|
45.0
|
1.0
|
CA
|
B:VAL99
|
4.4
|
48.9
|
1.0
|
CA
|
B:ALA102
|
4.4
|
40.6
|
1.0
|
N
|
B:ALA102
|
4.4
|
40.6
|
1.0
|
CG
|
B:GLU185
|
4.5
|
43.2
|
1.0
|
NE1
|
B:TRP187
|
4.5
|
34.4
|
1.0
|
N
|
B:ASP100
|
4.5
|
48.9
|
1.0
|
CA
|
B:GLY101
|
4.5
|
42.6
|
1.0
|
CA
|
B:ASP100
|
4.7
|
48.9
|
1.0
|
OG
|
B:SER180
|
4.8
|
42.1
|
1.0
|
CB
|
B:ASP100
|
4.9
|
50.3
|
1.0
|
OG1
|
B:THR105
|
4.9
|
45.2
|
1.0
|
C
|
B:ALA102
|
4.9
|
41.8
|
1.0
|
|
Calcium binding site 4 out
of 4 in 2ary
Go back to
Calcium Binding Sites List in 2ary
Calcium binding site 4 out
of 4 in the Catalytic Domain of Human Calpain-1
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of Catalytic Domain of Human Calpain-1 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca403
b:36.0
occ:1.00
|
O
|
B:HOH420
|
2.1
|
30.1
|
1.0
|
O
|
B:GLU333
|
2.2
|
31.3
|
1.0
|
O
|
B:MET329
|
2.3
|
40.9
|
1.0
|
OE2
|
B:GLU302
|
2.4
|
35.2
|
1.0
|
OE1
|
B:GLU302
|
2.5
|
38.2
|
1.0
|
OD1
|
B:ASP331
|
2.5
|
42.7
|
1.0
|
OD2
|
B:ASP309
|
2.5
|
40.5
|
1.0
|
CD
|
B:GLU302
|
2.7
|
34.0
|
1.0
|
OD1
|
B:ASP309
|
3.3
|
36.8
|
1.0
|
CG
|
B:ASP309
|
3.3
|
40.0
|
1.0
|
C
|
B:GLU333
|
3.4
|
31.9
|
1.0
|
CG
|
B:ASP331
|
3.4
|
37.6
|
1.0
|
C
|
B:MET329
|
3.6
|
41.8
|
1.0
|
OD2
|
B:ASP331
|
3.8
|
38.6
|
1.0
|
N
|
B:ASP331
|
3.9
|
35.6
|
1.0
|
N
|
B:GLU333
|
3.9
|
30.1
|
1.0
|
CA
|
B:GLU333
|
4.1
|
31.7
|
1.0
|
O
|
B:VAL327
|
4.2
|
40.9
|
1.0
|
CG
|
B:GLU302
|
4.2
|
32.2
|
1.0
|
N
|
B:MET329
|
4.4
|
44.8
|
1.0
|
O
|
B:HOH499
|
4.4
|
32.6
|
1.0
|
N
|
B:PHE334
|
4.4
|
29.9
|
1.0
|
N
|
B:GLU330
|
4.5
|
39.3
|
1.0
|
CA
|
B:GLU330
|
4.5
|
39.3
|
1.0
|
CA
|
B:MET329
|
4.5
|
44.1
|
1.0
|
CB
|
B:ASP331
|
4.6
|
36.4
|
1.0
|
O
|
B:HOH473
|
4.6
|
34.7
|
1.0
|
CB
|
B:GLU333
|
4.6
|
33.1
|
1.0
|
N
|
B:GLY332
|
4.6
|
32.2
|
1.0
|
CA
|
B:ASP331
|
4.6
|
35.3
|
1.0
|
CA
|
B:PHE334
|
4.7
|
29.7
|
1.0
|
C
|
B:GLU330
|
4.7
|
37.5
|
1.0
|
O
|
B:HOH424
|
4.7
|
36.3
|
1.0
|
CB
|
B:ASP309
|
4.7
|
39.5
|
1.0
|
C
|
B:GLY332
|
4.8
|
29.9
|
1.0
|
C
|
B:ASP331
|
4.9
|
34.9
|
1.0
|
CB
|
B:MET329
|
4.9
|
47.2
|
1.0
|
CB
|
B:PHE334
|
4.9
|
27.6
|
1.0
|
|
Reference:
T.L.Davis,
J.R.Walker,
P.J.Finerty,
F.Mackenzie,
E.M.Newman,
S.Dhe-Paganon.
The Crystal Structures of Human Calpains 1 and 9 Imply Diverse Mechanisms of Action and Auto-Inhibition J.Mol.Biol. V. 366 216 2007.
ISSN: ISSN 0022-2836
PubMed: 17157313
DOI: 10.1016/J.JMB.2006.11.037
Page generated: Fri Jul 12 08:49:18 2024
|